PMC:7253482 / 2777-3081 21 Projects
Annnotations
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T428 | 3-7 | CC | denotes | both |
| T429 | 8-16 | VBG | denotes | encoding |
| T430 | 17-19 | CD | denotes | 69 |
| T431 | 20-28 | JJ | denotes | N-linked |
| T432 | 29-35 | NN | denotes | glycan |
| T433 | 36-43 | NNS | denotes | sequons |
| T434 | 44-47 | IN | denotes | per |
| T435 | 48-56 | JJ | denotes | trimeric |
| T436 | 57-62 | NN | denotes | spike |
| T437 | 63-67 | IN | denotes | with |
| T438 | 68-78 | NN | denotes | SARS-CoV-2 |
| T439 | 79-89 | VBG | denotes | containing |
| T440 | 90-92 | CD | denotes | 66 |
| T441 | 93-98 | NNS | denotes | sites |
| T442 | 100-105 | DT | denotes | These |
| T443 | 106-119 | NNS | denotes | modifications |
| T444 | 120-125 | RB | denotes | often |
| T445 | 126-130 | VBP | denotes | mask |
| T446 | 131-142 | JJ | denotes | immunogenic |
| T447 | 143-150 | NN | denotes | protein |
| T448 | 151-159 | NNS | denotes | epitopes |
| T449 | 160-164 | IN | denotes | from |
| T450 | 165-168 | DT | denotes | the |
| T451 | 169-173 | NN | denotes | host |
| T452 | 174-181 | JJ | denotes | humoral |
| T453 | 182-188 | JJ | denotes | immune |
| T454 | 189-195 | NN | denotes | system |
| T455 | 196-198 | IN | denotes | by |
| T456 | 199-208 | VBG | denotes | occluding |
| T457 | 209-213 | PRP | denotes | them |
| T458 | 214-218 | IN | denotes | with |
| T459 | 219-231 | JJ | denotes | host-derived |
| T460 | 232-244 | NN | denotes | glycans16–18 |
| T461 | 246-250 | DT | denotes | This |
| T462 | 251-261 | NN | denotes | phenomenon |
| T463 | 262-264 | IN | denotes | of |
| T464 | 265-271 | JJ | denotes | immune |
| T465 | 272-279 | NN | denotes | evasion |
| T466 | 280-282 | IN | denotes | by |
| T467 | 283-292 | JJ | denotes | molecular |
| T468 | 293-300 | NN | denotes | mimicry |
| T469 | 301-304 | CC | denotes | and |
| R425 | T429 | T428 | arg1Of | encoding,both |
| R427 | T433 | T429 | arg2Of | sequons,encoding |
| R428 | T433 | T430 | arg1Of | sequons,69 |
| R429 | T433 | T431 | arg1Of | sequons,N-linked |
| R430 | T433 | T432 | arg1Of | sequons,glycan |
| R431 | T433 | T434 | arg1Of | sequons,per |
| R432 | T436 | T434 | arg2Of | spike,per |
| R433 | T436 | T435 | arg1Of | spike,trimeric |
| R434 | T436 | T437 | arg1Of | spike,with |
| R435 | T438 | T437 | arg2Of | SARS-CoV-2,with |
| R436 | T438 | T439 | arg1Of | SARS-CoV-2,containing |
| R437 | T441 | T439 | arg2Of | sites,containing |
| R438 | T441 | T440 | arg1Of | sites,66 |
| R439 | T443 | T442 | arg1Of | modifications,These |
| R440 | T445 | T444 | arg1Of | mask,often |
| R441 | T443 | T445 | arg1Of | modifications,mask |
| R442 | T448 | T445 | arg2Of | epitopes,mask |
| R443 | T448 | T446 | arg1Of | epitopes,immunogenic |
| R444 | T448 | T447 | arg1Of | epitopes,protein |
| R445 | T448 | T449 | arg1Of | epitopes,from |
| R446 | T454 | T449 | arg2Of | system,from |
| R447 | T454 | T450 | arg1Of | system,the |
| R448 | T454 | T451 | arg1Of | system,host |
| R449 | T454 | T452 | arg1Of | system,humoral |
| R450 | T454 | T453 | arg1Of | system,immune |
| R451 | T445 | T455 | arg1Of | mask,by |
| R452 | T456 | T455 | arg2Of | occluding,by |
| R453 | T443 | T456 | arg1Of | modifications,occluding |
| R454 | T457 | T456 | arg2Of | them,occluding |
| R455 | T456 | T458 | arg1Of | occluding,with |
| R456 | T460 | T458 | arg2Of | glycans16–18,with |
| R457 | T460 | T459 | arg1Of | glycans16–18,host-derived |
| R458 | T462 | T461 | arg1Of | phenomenon,This |
| R459 | T462 | T463 | arg1Of | phenomenon,of |
| R460 | T465 | T463 | arg2Of | evasion,of |
| R461 | T465 | T464 | arg1Of | evasion,immune |
| R462 | T462 | T466 | arg1Of | phenomenon,by |
| R463 | T469 | T466 | arg2Of | and,by |
| R464 | T468 | T467 | arg1Of | mimicry,molecular |
| R465 | T468 | T469 | arg1Of | mimicry,and |